Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AB, Abbvie, AffaMed, AgreementSM, Asian, ATM, BCF, Biden, biliary, bupropion, CBC, Charter, chrondrocyte, contradictory, Curley, Effexor, euphoria, exceeding, explicit, Fluoxetine, furniture, host, inquired, Joanne, merged, Neurocrine, nondilutive, operationally, ophthalmologic, overuse, PALISADE, parity, paroxetine, pathogenic, Paxil, PCT, peripheral, perspective, Prozac, ranking, remanded, repayment, Rexulti, sertraline, step, stream, Subtopic, systematically, Thirteen, trauma, Treaty, Trintellix, unexercised, unrest, upholding, venlaxafine, venture, veterinary, Viibryd, voluntarily, Wellbutrin, Willian, workplace, Zoloft
Removed:
Acea, administering, advanced, affiliate, alleviate, Avanir, banking, BioCardia, Biohaven, biology, BioMarker, BioTime, bone, budgeting, built, Cadent, cancer, CardioSafe, cardiotoxicity, CBV, Cellerant, Cerecor, CHC, CIRM, classifying, comprising, concentration, constantly, conventional, Cooperative, customized, Cytori, delineated, developer, differentiating, differentiation, divide, donated, doubt, dual, efficiently, embryonic, engineering, ethical, exert, extinguishment, Fava, fertilization, fertilized, finance, Fisher, formed, Fujifilm, GE, GlyB, harming, Harvard, HemoGenix, hERG, hESC, hurt, immortalized, incorrect, insight, IVF, lessee, live, manipulation, Maurizio, meaningfully, mimic, misinterpret, monotherapy, move, MSA, Neuralstem, NeuroRx, NMDA, nontoxic, optimization, optimized, orally, organ, organizational, Organovo, originally, OTC, partly, partnership, path, physiologically, PluriStem, POC, predicting, predisposition, preferable, prepayment, preventing, principle, procedure, reside, River, sector, Society, span, Squibb, Stemina, Stroke, sublicensed, Summary, surrogate, technically, thereof, thereunder, Thermo, threatening, top, transform, transformed, unchanged, underestimate, validation, voice, VSTA, workload, wrong, yearly
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Subsidiaries of the Registrant
- 23.1 Consents of Experts and Counsel
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Associated VTGN transcripts
VTGN similar filings
Filing view
External links
EXHIBIT 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of VistaGen Therapeutics, Inc. (the “Company ”) hereby certifies, to such officer’s knowledge, that:
(i) the accompanying Annual Report on Form 10-K of the Company for the annual period ended March 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
June 29, 2021
/s/ Shawn K. Singh
Shawn K. Singh, JD
Principal Executive Officer
/s/ Jerrold D. Dotson
Jerrold D. Dotson
Principal Financial Officer